|
2017 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyàs, Elisabet
; Corominas Faja, Bruna
; Muñoz-San Martín, María
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyàs, Elisabet
; Corominas Faja, Bruna
; Muñoz-San Martín, María
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
|
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyàs, Elisabet
; Corominas Faja, Bruna
; Muñoz-San Martín, María
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
BRCA1 haploinsufficiency cell-autonomously activates RANKL expression and generates denosumab-responsive breast cancerinitiating cells |
Cuyàs, Elisabet
; Corominas Faja, Bruna
; Muñoz-San Martín, María
; Martin Castillo, Begoña
; Lupu, Ruth
; Brunet i Vidal, Joan
; Bosch Barrera, Joaquim
; Menéndez Menéndez, Javier Abel
|
|
|
2014 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; Rodríguez Gallego, Esther
; Cufí González, Sílvia
; Corominas Faja, Bruna
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; Rodríguez Gallego, Esther
; Cufí González, Sílvia
; Corominas Faja, Bruna
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; Rodríguez Gallego, Esther
; Cufí González, Sílvia
; Corominas Faja, Bruna
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
5 juny 2018 |
Oncobiguanides: Paracelsus’ law and nonconventional routes for administering diabetobiguanides for cancer treatment |
Menéndez Menéndez, Javier Abel
; Quirantes Piné, Rosa
; Rodríguez Gallego, Esther
; Cufí González, Sílvia
; Corominas Faja, Bruna
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Segura Carretero, Antonio
; Joven, Jorge
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyàs, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; Rodríguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
|
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyàs, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; Rodríguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyàs, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; Rodríguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
20 maig 2015 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyàs, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; Rodríguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
15 febrer 2020 |
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotype |
Cuyàs, Elisabet
; Fernández Arroyo, Salvador
; Corominas Faja, Bruna
; Rodríguez Gallego, Esther
; Bosch Barrera, Joaquim
; Martin Castillo, Begoña
; Llorens Duran, Rafael de
; Joven, Jorge
; Menéndez Menéndez, Javier Abel
|
|
|
|
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo, Angel
; Porta, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza Gutiérrez, Salvador
; Menéndez Menéndez, Javier Abel
|
|
|
|
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo, Angel
; Porta, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza Gutiérrez, Salvador
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo, Ángel
; Porta, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza Gutiérrez, Salvador
; Menéndez Menéndez, Javier Abel
|
|
|
15 febrer 2020 |
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo, Ángel
; Porta Balanyà, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza, S.
; Menéndez Menéndez, Javier Abel
|
|
|
3 març 2016 |
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin |
Bosch Barrera, Joaquim
; Sais, Elia
; Cañete Abajo, Noemí
; Marruecos, Jordi
; Cuyàs, Elisabet
; Izquierdo i Font, Àngel Xavier
; Porta Balanyà, Rut
; Haro, Manel
; Brunet i Vidal, Joan
; Pedraza, S.
; Menéndez Menéndez, Javier Abel
|
|
|
12 setembre 2016 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
|
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
|
|
5 juny 2018 |
Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer |
Queralt, Bernardo
; Cuyàs, Elisabet
; Bosch Barrera, Joaquim
; Massaguer i Vall-llovera, Anna
; Llorens Duran, Rafael de
; Martin Castillo, Begoña
; Brunet i Vidal, Joan
; Salazar, Ramon
; Menéndez Menéndez, Javier Abel
|
